The Phosphatidylinositol 3-Kinase-Akt Pathway Limits Lipopolysaccharide Activation of Signaling Pathways and Expression of Inflammatory Mediators in Human Monocytic Cells
Top Cited Papers
Open Access
- 1 August 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (35), 32124-32132
- https://doi.org/10.1074/jbc.m203298200
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Toll-like Receptor 2 and 4 (TLR2 and TLR4) Agonists Differentially Regulate Secretory Interleukin-1 Receptor Antagonist Gene Expression in MacrophagesPublished by Elsevier ,2002
- An Inhibitory Role of the Phosphatidylinositol 3-Kinase-signaling Pathway in Vascular Endothelial Growth Factor-induced Tissue Factor ExpressionPublished by Elsevier ,2001
- Akt Down-regulation of p38 Signaling Provides a Novel Mechanism of Vascular Endothelial Growth Factor-mediated Cytoprotection in Endothelial CellsJournal of Biological Chemistry, 2001
- Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38Journal of Biological Chemistry, 2001
- Signaling by Toll-Like Receptor 2 and 4 Agonists Results in Differential Gene Expression in Murine MacrophagesInfection and Immunity, 2001
- Diagnosis and nonsurgical management of osteoarthritisAnnals Of The Rheumatic Diseases, 2001
- Differential Effects of Lipopolysaccharide and Tumor Necrosis Factor on Monocytic IκB Kinase Signalsome Activation and IκB ProteolysisPublished by Elsevier ,1999
- Wortmannin, a Specific Inhibitor of Phosphatidylinositol-3-kinase, Enhances LPS-Induced NO Production from Murine Peritoneal MacrophagesBiochemical and Biophysical Research Communications, 1997
- Regulation of the Tissue Factor Gene in Human Monocytic CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites.The Journal of Experimental Medicine, 1991